Search Results 871-880 of 17108 for egfr

  1. Effect of TTFields (150 kHz) in Non-small Cell Lung Cancer (NSCLC) Patients With 1-10 Brain Metastases Following Radiosurgery (METIS) - Mayo Clinic

    ... (EGFR), ROS-1 proto-oncogene, and proto-oncogene B-RAF. Patients who have a single, operable brain metastasis. Patients with significant edema leading to ...

  2. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study - Mayo Clinic

    Chronic renal insufficiency as defined by serum creatinine \> 2.5 mg/dL or has an estimated glomerular filtration rate (eGFR) \< 30 mL/min utilizing the ...

  3. Stem cells may offer new hope for end-stage kidney disease treatment

    Mayo Clinic researchers found a potential way to improve access for patients with end-stage kidney disease to hemodialysis.

  4. TN-401, A Recombinant Adeno-associated Virus Serotype 9 (AAV9) Containing Plakophilin-2 (PKP2) Transgene, In Adults With PKP2 Mutation-associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) - Mayo Clinic

    Clinically significant renal disease (e.g., estimated glomerular filtration rate [eGFR] 160 mmHg or diastolic blood pressure [DBP] > 100 mmHg), autoimmune ...

  5. A Study to Evaluate Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant - Mayo Clinic

    The purpose of this study is test the hypothesis that plasmapheresis plus rituximab prior to or shortly after kidney transplantation can prevent recurrent Focal ...

  6. A Study to Test the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer - Mayo Clinic

    Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as ...

  7. Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: The TAKE IT Trial - Mayo Clinic

    About this study. The investigators will evaluate a technology-enabled strategy designed to promote medication adherence, routinely monitor regimen use, ...

  8. A Study Of The Drugs Selumetinib Vs. Carboplatin And Vincristine In Patients With Low-Grade Glioma - Mayo Clinic

    About this study. This study aims to demonstrate that the efficacy of treatment with selumetinib as measured by event-free survival (EFS) is non-inferior ...

  9. Cirrhosis Clinical Trials - Mayo Clinic Research

    Erlotinib (Tarceva) is a human EGFR type 1 tyrosine kinase inhibitor and offers greater survival benefit to EGFR positive patients. This study will assist ...

  10. AMBER-HFpEF: Assessment Of CK-4021586 In A Multi-Center, Blinded Evaluation Of Safety And Tolerability Results In HFpEF - Mayo Clinic

    This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF. Participation eligibility. Participant eligibility includes age, gender, type ...